The obesity treatment market is drastically underserved and considerably underdeveloped. While bariatric surgery has significant improvement in recent decades, evolving to become the gold standard for proven treatment in the absence of effective pharmacotherapy, only 1% of obese patients opt for surgical intervention. Less-invasive that surgery, obesity treatment medical devices have seen notable advancement in recent years, and several technologies have gained international adoption; however, long-term efficacy is still lacking, prompting continued development and ever-changing market competition.
The report “MediFocus: Medical Devices for the Treatment of Obesity” (http://www.reportsnreports.com/reports/247499-medifocus-medical-devices-for-the-treatment-of-obesity.html) offers a comprehensive analysis of the global obesity medical device market, including development and approval of artificial fullness devices, deep brain stimulation devices, endoscopic surgical devices, gastric electrical stimulation devices, gastric emptying aspiration tools, malabsorption devices, neuronal blocking technology, and restrictive devices. Included within is an analysis of the pipeline and approved obesity treatment products, with a focus on safety, efficacy and commercial positioning, as well as an examination of companies currently active in the field. The report identifies and evaluates key trends and advances shaping the global obesity medical device market, highlighting testimonials from top physicians around the world who are already utilizing the devices, with a focus on next-generation technologies. The report provides insight into the competitive obesity medical device landscape, including new companies approaching commercialization and pipeline products in development.
Scope of the report “Medical Devices for the Treatment of Obesity” covers:
- An overview of the international obesity treatment medical device landscape
- Investigation of current and future market competition for obesity medical devices
- Competitive assessment with device strengths and weaknesses analyzed
- Marketed and pipeline product profiles covering efficacy, safety, clinical study details, regulatory approvals, and commercial positioning
- Evaluation of technology trends to assess pipeline product strength
- Overview of all devices in development, including design considerations, efficacy reports, and physician perception
- Coverage of key market players with portfolio assessment and SWOT analysis
- Direct quotes from Key Opinion Leaders (KOL) currently using obesity medical devices
Reasons to buy
- Understand the trends shaping and driving the obesity medical device markets
- Realize device preferences of physicians who have performed dozens of implantations already
- Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth
- What’s the next big thing in the global Obesity Medical Device market? Identify, understand and capitalize
Companies profiled in this report : Allergan, Apollo Endosurgery, Inc., Aspire Bariatrics, Inc., Agency for Medical Innovation, Bariatric Solutions, Baronova, BaroSense, Inc., BFKW, Cousin Biotech, CR Bard, Endalis Laboratory, EndoGastric Solutions, EndoSphere, Inc., EnteroMedics, Inc., Ethicon Endo-Surgery, GI Dynamics, Helioscopie, IntraPace, Inc., Medical Innovation Development, MetaCure Inc., Obalon Therapeutics, ReShape Medical, Spatz Medical and ValenTx, Inc.
Contact [email protected] for further information.